iiinova — where your digital self keeps evolving

Reposted by Andrew Bowskill

Nadine Hillock @nadinehillock.bsky.social · 14/07/2025

‘Pharma companies make money on a new drug by selling a lot or charging a lot - but with antimicrobials neither is possible.’ - Andrew Bowskill #AAMRNet. Delinking funding from use is the only way to stimulate investment in new antimicrobials #MTPConnect #AMR #antimicrobials @drewabow.bsky.social

031

Reposted by Andrew Bowskill

Nadine Hillock @nadinehillock.bsky.social · 08/04/2025

Timely access to appropriate antimicrobials is essential for patient care, antimicrobial stewardship & minimising the risk of resistance - excellent summary of the issues here: amr.solutions/2025/04/07/y... Thanks to @johnhrexmd.bsky.social for highlighting our paper #AMR #AntibioticAccess #AMS 💊

amr.solutions

You reach for the antibiotic ... and it's not there!

Dear All (with thanks to Louise for co-authoring and with a wonkish alert … settle in for the ride!), Today’s newsletter discusses the intersection of three themes around antibiotic access. Recall fir...

031

Reposted by Andrew Bowskill

JAC-AMR @jac-amr.bsky.social · 12/03/2025

The access pathway for unregistered medicines in Australia is used extensively to access antimicrobials, including for life-threatening infections Difficulty accessing appropriate antimicrobials is not only a problem affecting LMICs doi.org/10.1093/jaca... @nadinehillock.bsky.social

doi.org

062

Reposted by Andrew Bowskill

Anita Williams @catanita.bsky.social · 13/01/2025

The survey closes Feb 28 2025 It is important many Australian researchers complete this survey to present as strong a voice as possible for #AMR to be central to the Strategy Thanks to @drewabow.bsky.social and AAMRNet for bringing this to our attention. Sign up to receive the AAMRNet newsletter

mtpconnect.org.au

Australian Antimicrobial Resistance Network (AAMRNet) : MTPConnect

031